Search results for "DDE"

showing 10 items of 1858 documents

The mainz-pouch (mixed augmentation ileum 'n zecum) for bladder augmentation and continent diversion

1985

The ideal urinary reservoir constructed from bowel material should be a low-pressure system with a high capacity, capable of preventing upper tract deterioration resulting from ureteral obstruction or reflux. It should achieve reliable control of continence and assure easy emptying of the reservoir. In the Mainz-pouch, the combination of cecum and ileum, the latter of which is able to absorb pressure waves created by the cecum, produces a low-pressure system with a high capacity immediately postoperatively. By incorporating large bowel in our pouch, ureteral implantation can be done using a simple and reliable standard antireflux technique with a submucosal tunnel. The Mainz-pouch has been …

medicine.medical_specialtyUrinary bladderbusiness.industryUrologyUrinary systemmedicine.medical_treatmentUrinary diversionInvaginationSurgeryCystectomymedicine.anatomical_structureBladder augmentationmedicinePouchbusinessContinent Urinary DiversionWorld Journal of Urology
researchProduct

Follow-up results of embolization therapy for palliation of incurable bladder carcinoma

1985

Embolization therapy of the renal artery (N=10), hypogastric arteries (N=18) and ureter (N=24) was performed in 41 patients with incurable bladder carcinoma for palliation of gross hematuria and severe dysuria. Careful follow-up of the patients until death gave a mean survival time of 12.3 months after embolization; 6 patients are still alive. The results show that embolization therapy is justified for management of bleeding and dysuric complaints. Ureteral occlusion alone has almost no effect on hematuria. Combined embolization procedures yield better results than occlusion of the vessels or the ureter. Ureteral occlusion with a detachable balloon is superior to embolization with tissue ad…

medicine.medical_specialtyUrinary bladderbusiness.industryUrologymedicine.medical_treatmenturologic and male genital diseasesmedicine.diseaseInternal iliac arteryfemale genital diseases and pregnancy complicationsSurgerymedicine.anatomical_structureUretermedicine.arteryOcclusionCarcinomaMedicineDysuriaRadiologyEmbolizationRenal arterymedicine.symptombusinessWorld Journal of Urology
researchProduct

Treatment of Patients with Bladder Exstrophy or Incontinent Epispadias

1997

Objective: To determine the late outcome concerning urinary continence, late complications, sexuality, and fertility in patients with the exstrophy-epispadias complex. Methods: Until July 1994, 115 patients underwent surgical treatment at our institution. The mean follow-up period in 102 patients is 16.7 years. Urinary diversion was performed in 88 patients, a modified Young-Dees procedure in 8, a sling plasty in 3, and genital reconstruction alone in 3 patients. Results: The present continence rates are 96% for rectal reservoirs, 97% for Mainz pouch I, and 67% for the modified Young-Dees procedure. The upper tracts have remained stable, and no bowel neoplasms have developed. 16 of 17 women…

medicine.medical_specialtyUrinary continencebusiness.industryUrologymedicine.medical_treatmentUrinary diversionUterine prolapseUrinary incontinenceEpispadiasmedicine.diseaseIntroitusSurgeryBladder exstrophymedicineEpididymitismedicine.symptombusinessEuropean Urology
researchProduct

Electrochemical detection and screening of bladder cancer recurrence using direct electrochemical analysis of urine: A non-invasive tool for diagnosis

2018

Although detection of urothelial cell carcinoma (or bladder cancer, BC) can be performed via cytological, molecular and genetic marker tests on urine, cystoscopy, an invasive technique, still remains as the gold methodology in clinical practice. It is presented a non-invasive method for detecting BC recurrence consisting of a direct electrochemical test in urine combining voltammetric data at gold and glassy carbon electrodes. The diagnosis is based on the ratio between characteristic voltammetric features recorded for tryptophan, serotonin and melatonin and other related metabolites. The method was tested by means of a clinical trial with 30 patients diagnosed of bladder cancer and a two c…

medicine.medical_specialtyUrinary systemUrology02 engineering and technologyElectrochemical detectionUrineUrine010402 general chemistry01 natural sciencesUrothelial cell carcinomaMaterials ChemistrymedicineElectrochemistryElectrical and Electronic EngineeringInstrumentationBladder cancermedicine.diagnostic_testbusiness.industryNon invasiveBladder cancerMetals and AlloysCystoscopyNon-invasive diagnostic021001 nanoscience & nanotechnologyCondensed Matter Physicsmedicine.disease0104 chemical sciencesSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsClinical trial0210 nano-technologybusiness
researchProduct

Deep Learning Predicts Molecular Subtype of Muscle-invasive Bladder Cancer from Conventional Histopathological Slides.

2020

Abstract Background Muscle-invasive bladder cancer (MIBC) is the second most common genitourinary malignancy, and is associated with high morbidity and mortality. Recently, molecular subtypes of MIBC have been identified, which have important clinical implications. Objective In the current study, we tried to predict the molecular subtype of MIBC samples from conventional histomorphology alone using deep learning. Design, setting, and participants Two cohorts of patients with MIBC were used: (1) The Cancer Genome Atlas Urothelial Bladder Carcinoma dataset including 407 patients and (2) our own cohort including 16 patients with treatment-naive, primary resected MIBC. This resulted in a total …

medicine.medical_specialtyUrology030232 urology & nephrologyH&E stainDiseaseMalignancy03 medical and health sciences0302 clinical medicineDeep LearningCarcinomamedicineHumansNeoplasm InvasivenessBladder cancerReceiver operating characteristicbusiness.industryDeep learningmedicine.diseaseMolecular Diagnostic TechniquesUrinary Bladder Neoplasms030220 oncology & carcinogenesisHistopathologyArtificial intelligenceRadiologybusinessForecastingEuropean urology
researchProduct

Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis.

2003

Abstract Objective: Pathologists play a pivotal role in the diagnosis and in the report of the pathological features related to prognosis. Methods: To meet these endpoints, the following issues must be accomplished: adequate information about the patient history, proper handling of the specimens, identification of the reliable histopathological techniques necessary to reach the more detailed diagnostic information and evaluate the prognostic variables, and a standardized pathological report. Results: Recent efforts to standardize the histopathological evaluation have generated significant confusion among the urological and pathological communities as well. No consensus has been achieved abo…

medicine.medical_specialtyUrologyBiopsySpecimen HandlingmedicineHumansMedical historyKidney PelvisPhysician's RoleGrading (tumors)Neoplasm StagingBladder cancerPathology Clinicalbusiness.industryUreteral NeoplasmsAnatomical pathologyProfessional PracticePathology Reportmedicine.diseasePrognosisKidney NeoplasmsSurgerySquamous carcinomamedicine.anatomical_structureEpidermoid carcinomaUrinary Bladder NeoplasmsRadiologybusinessRenal pelvisEuropean urology
researchProduct

The pharmacological rationale for combining muscarinic receptor antagonists and beta-adrenoceptor agonists in the treatment of airway and bladder dis…

2014

Highlights • Muscarinic receptors increase smooth muscle tone in airways and urinary bladder. • β-Adrenoceptors relax smooth muscle tone and oppose muscarinic contraction. • Opposition involves transmitter release, signal transduction and receptor expression. • This supports the combined use of muscarinic antagonists and β-adrenoceptor agonists.

medicine.medical_specialtyUrologyDiseaseMuscarinic AntagonistsPharmacologyArticleβ adrenoceptorchemistry.chemical_compoundInternal medicineReceptors Adrenergic betaMuscarinic acetylcholine receptorDrug DiscoveryMuscarinic acetylcholine receptor M4RAT URINARY-BLADDERMedicineAnimalsHumansCyclic adenosine monophosphateADRENERGIC RELAXATIONLung Diseases ObstructivePROTEIN-KINASE-CReceptorTRACHEAL SMOOTH-MUSCLEPharmacologybusiness.industryUrinary Bladder DiseasesMuscarinic acetylcholine receptor M3Muscarinic acetylcholine receptor M2ACETYLCHOLINE-RELEASEAdrenergic beta-Agonistsmedicine.diseaseReceptors MuscarinicEndocrinologyNONNEURONAL CHOLINERGIC SYSTEMchemistryGUINEA-PIG TRACHEADrug Therapy CombinationCYCLIC ADENOSINE-MONOPHOSPHATECA2+-ACTIVATED K+ CHANNELAirwaybusinessUrinary bladder diseaseAUTORADIOGRAPHIC VISUALIZATIONAcetylcholinemedicine.drug
researchProduct

Do overactive bladder symptoms and their treatment-associated changes exhibit a normal distribution? Implications for analysis and reporting

2020

Aims: To explore the use of means vs medians (assuming or not the presence of normal distribution) in studies reporting overactive bladder syndrome symptoms and to test for normal distribution of basal values and treatment-associated changes thereof in two large noninterventional studies. Methods: Systematic review of all original studies reporting on at least one overactive bladder syndrome symptom published in four leading urology journals in 2016 to 2017. Testing of the normal distribution of urgency, incontinence, frequency, and nocturia in two large noninterventional studies (n = 1335 and 745). Results: Among 48 eligible articles, 86% reported means (assuming a normal distribution), 6%…

medicine.medical_specialtyUrologyMedizin030232 urology & nephrologyNormal Distribution610 MedizinNormal distribution03 medical and health sciencesBasal (phylogenetics)0302 clinical medicineInternal medicine610 Medical sciencesmedicineNocturiaHumansBaseline values030219 obstetrics & reproductive medicinebusiness.industryUrinary Bladder Overactivemedicine.diseaseOveractive bladder syndrome3. Good healthUrinary IncontinenceOveractive bladderPropiverineNocturiaNeurology (clinical)medicine.symptombusinessmedicine.drug
researchProduct

Continent diversion with the Mainz pouch.

1996

From 1983 until July 1994, 561 patients in 2 urology departments (Mainz and Wuppertal) underwent a Mainz pouch 1 procedure. The Mainz pouch 1 was used for bladder augmentation in 60 patients, for orthotopic bladder substitution in 61 patients, and for continent cutaneous urinary diversion in 440 patients. In the group of continent cutaneous urinary diversion, the continence mechanism applied was an ileal intussusception nipple in 270 patients, an appendix stoma in 146 patients, a submucosal seromuscular bowel-flap tube in 14 patients, and a submucosal full-thickness bowel-flap tube in 10 patients. Indications for urinary diversion were bladder cancer in 339 patients, anatomical or functiona…

medicine.medical_specialtyUrologyUrinary systemmedicine.medical_treatmentUrinary LeakagePostoperative ComplicationsIleumRisk FactorsmedicineHumansCecumBladder cancerbusiness.industryUrinary retentionUrinary diversionUrinary Reservoirs Continentmedicine.diseasePrognosisAppendixSurgerySurvival Ratemedicine.anatomical_structureBladder augmentationEvaluation Studies as TopicPouchmedicine.symptombusinessFollow-Up StudiesWorld journal of urology
researchProduct

Results of conservative treatment (transurethral resection plus adjuvant intravesical chemotherapy) in patients with primary T1, G3 transitional cell…

1996

Objectives. To evaluate a selected population of 50 consecutive patients with primary T1, G3 bladder transitional cell carcinoma in the absence of carcinoma in situ (Tis) treated with a bladder-sparing approach. Methods. Between January 1983 and December 1992, all patients were treated by transurethral resection (TUR) plus adjuvant intravesical chemotherapy over 1 year. In most cases, doxorubicin, epirubicin, and mitomycin were used alone or in combination. Results. At a mean follow-up period of 52 months (range, 18 to 126), 16 of 50 patients (32%) showed a recurrent superficial tumor. The recurrent lesion was of Stage T1 in 11 (22%) cases, but was a T1, G3 tumor only in 5 cases (10%). In 2…

medicine.medical_specialtyUrologymedicine.medical_treatmentPopulationAntineoplastic AgentsMitomycinsSettore MED/24 - UrologiaCystectomyUrethraCarcinomamedicineHumansBACILLUS CALMETTE-GUERINeducationEpirubicinNeoplasm StagingCarcinoma Transitional Celleducation.field_of_studyUrinary bladderBladder cancerbusiness.industryCarcinoma in situmedicine.diseaseCombined Modality TherapyCANCERSurgeryAdministration Intravesicalmedicine.anatomical_structureTransitional cell carcinomaUrinary Bladder NeoplasmsChemotherapy AdjuvantDoxorubicinSurgical Procedures OperativeNeoplasm Recurrence LocalbusinessFollow-Up StudiesEpirubicinmedicine.drugUrology
researchProduct